Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NYSE:GSK
Tag: NYSE:GSK
Analyst Activity – Citigroup Inc. Reiterates Neutral on GlaxoSmithKline PLC (NYSE:GSK)
ME Staff
-
July 27, 2017
0
GlaxoSmithKline plc. (ADR)(NYSE:GSK) To Offload 130 Brands As Part of £1...
-
July 27, 2017
0
Analyst Activity – J P Morgan Chase & Co Reiterates Neutral...
ME Staff
-
July 24, 2017
0
Analyst Activity – J P Morgan Chase & Co Reiterates Neutral...
ME Staff
-
July 24, 2017
0
GlaxoSmithKline Plc (ADR) (NYSE:GSK) Reveals Plan To Sell Off Horlicks Brand
Andy Parker
-
July 20, 2017
0
GlaxoSmithKline plc. (ADR)(NYSE:GSK) Inks $43 Million Artificial Intelligence Deal To Develop...
-
July 5, 2017
0
Novartis AG (ADR) (NYSE:NVS) Enbrel Biosimilar Erelzi Approved In Europe
-
June 29, 2017
0
GlaxoSmithKline plc (ADR) (NYSE:GSK) Presents Positive Data From Phase III Shingles...
-
June 23, 2017
0
GlaxoSmithKline plc (ADR) (NYSE:GSK) To Receive $235M From Teva Pharmaceutical Industries...
Andy Parker
-
June 22, 2017
0
European Commission Clears Novartis AG (ADR) (NYSE:NVS) Blood Cancer Drug
Andy Parker
-
June 20, 2017
0
1
2
3
4
...
9
Page 3 of 9
